BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19123899)

  • 1. Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters?
    Linskey ME
    J Neurosurg; 2008 Dec; 109 Suppl():129-36. PubMed ID: 19123899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing.
    Han JH; Kim DG; Chung HT; Paek SH; Jung HW
    Adv Tech Stand Neurosurg; 2016; (43):3-36. PubMed ID: 26508404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma.
    Kano H; Kondziolka D; Khan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2009 Oct; 111(4):863-73. PubMed ID: 19284227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
    Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma.
    Paek SH; Chung HT; Jeong SS; Park CK; Kim CY; Kim JE; Kim DG; Jung HW
    Cancer; 2005 Aug; 104(3):580-90. PubMed ID: 15952200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
    Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
    J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion.
    Kim YH; Kim DG; Han JH; Chung HT; Kim IK; Song SW; Park JH; Kim JW; Kim YH; Park CK; Kim CY; Paek SH; Jung HW
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):61-7. PubMed ID: 22580122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearing preservation after intracanalicular vestibular schwannoma radiosurgery.
    Niranjan A; Mathieu D; Flickinger JC; Kondziolka D; Lunsford LD
    Neurosurgery; 2008 Dec; 63(6):1054-62; discussion 1062-3. PubMed ID: 19057318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preserved Cochlear CISS Signal is a Predictor for Hearing Preservation in Patients Treated for Vestibular Schwannoma With Stereotactic Radiosurgery.
    Prabhu V; Kondziolka D; Hill TC; Benjamin CG; Shinseki MS; Golfinos JG; Roland JT; Fatterpekar GM
    Otol Neurotol; 2018 Jun; 39(5):628-631. PubMed ID: 29561382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
    Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.
    Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ
    Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation exposure of normal temporal bone structures during stereotactically guided gamma knife surgery for vestibular schwannomas.
    Linskey ME; Johnstone PA; O'Leary M; Goetsch S
    J Neurosurg; 2003 Apr; 98(4):800-6. PubMed ID: 12691405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma.
    Hayden Gephart MG; Hansasuta A; Balise RR; Choi C; Sakamoto GT; Venteicher AS; Soltys SG; Gibbs IC; Harsh GR; Adler JR; Chang SD
    World Neurosurg; 2013; 80(3-4):359-63. PubMed ID: 22484770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
    Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
    Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.
    Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY
    Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
    Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
    Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up reveals low toxicity of radiosurgery for vestibular schwannoma.
    Rutten I; Baumert BG; Seidel L; Kotolenko S; Collignon J; Kaschten B; Albert A; Martin D; Deneufbourg JM; Demanez JP; Stevenaert A
    Radiother Oncol; 2007 Jan; 82(1):83-9. PubMed ID: 17182142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.